Canada markets close in 4 hours 9 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1600+0.0100 (+6.67%)
As of 11:40AM EDT. Market open.

Kane Biotech Inc.

100 Innovation Drive
Suite 290
Winnipeg, MB R3T 6G2
Canada
204-453-1301
https://kanebiotech.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Marc EdwardsPresident, CEO & Director268.5kN/AN/A
Mr. Ray DupuisChief Financial Officer161.69kN/AN/A
Dr. Robert B. Huizinga CNeph(C), M.Sc., MSc(Epi), Ph.D., R.N., RN NNCExecutive Chairman & Member of Scientific Advisory BoardN/AN/A1965
Dr. Gregory S. Schultz Ph.D.Chief Scientific Officer & Member of Scientific Advisory BoardN/AN/A1950
Lorne GorberInvestor RelationsN/AN/AN/A
Ms. Lori ChristofalosVice President of Quality & ComplianceN/AN/AN/A
Ms. Wendy NachtigallDirector of MarketingN/AN/AN/A
Nicole SendeyInvestor Relations AdviserN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

Corporate Governance

Kane Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.